Xeljanz is a medication that has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis in adults. It belongs to a class of drugs known as Janus kinase (JAK) inhibitors, which work by targeting specific enzymes in the body that are involved in the inflammatory process.

This medication is typically prescribed for patients who have not responded well to other treatments for rheumatoid arthritis, such as methotrexate. Xeljanz can help reduce pain, swelling, and joint damage associated with this chronic autoimmune disease.

It is important to follow your healthcare provider’s instructions when taking Xeljanz, as it can have potential side effects such as an increased risk of infections, liver problems, and gastrointestinal perforations. Your doctor may also recommend regular monitoring of your blood counts and liver function while on this medication.

It is important to inform your healthcare provider about any other medications or supplements you are taking, as they may interact with Xeljanz. Additionally, it is not recommended to take Xeljanz if you are pregnant, planning to become pregnant, or breastfeeding.

Overall, Xeljanz can be an effective treatment option for individuals with rheumatoid arthritis who have not found relief with other medications. It is important to have open communication with your healthcare provider about your symptoms and any concerns you may have while taking this medication.